Your browser doesn't support javascript.
loading
Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma.
Abd Elwakil, Mahmoud M; Mabrouk, Moustafa T; Helmy, Maged W; Abdelfattah, Elsayeda-Zeinab A; Khiste, Sachin K; Elkhodairy, Kadria A; Elzoghby, Ahmed O.
Afiliação
  • Abd Elwakil MM; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
  • Mabrouk MT; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
  • Helmy MW; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
  • Abdelfattah EA; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
  • Khiste SK; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt.
  • Elkhodairy KA; Medical Research Institute (MRI), Alexandria University, Alexandria 21527, Egypt.
  • Elzoghby AO; Division of Engineering in Medicine, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA (Current Address).
Nanomedicine (Lond) ; 13(16): 2015-2035, 2018 08.
Article em En | MEDLINE | ID: mdl-30191764

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Condroitina / Ácido Elágico / Nanocompostos / Nanopartículas / Lactoferrina / Neoplasias Pulmonares Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Condroitina / Ácido Elágico / Nanocompostos / Nanopartículas / Lactoferrina / Neoplasias Pulmonares Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article